For adults with moderate to severe Crohn’s disease.
†Quarterly analysis of claims data from January 2023–December 2025.
Crohn’s patient stories
Stories from real people living with Crohn's
“With ENTYVIO, I was finally able to be off steroids. ENTYVIO was really working for me.*”
– Krista, real patient living with Crohn’s
"I’m prepared with knowledge… so my healthcare team and I can make the right decisions about my care. After starting on ENTYVIO, I noticed a change that made me happy: relief from some of my symptoms.*”
– Donna, real patient living with Crohn’s
"I’m prepared with knowledge… so my healthcare team and I can make the right decisions about my care. After starting on ENTYVIO, I noticed a change that made me happy: relief from some of my symptoms.*”
– Donna, real patient living with Crohn’s
“There were some symptoms that could not be ignored. And there were times when I couldn’t explain away the pain. I had to admit that I could not beat Crohn’s on my own.”
– Ben, real patient living with Crohn’s
The real patients profiled on these pages were compensated for sharing their stories.
*Some patients taking ENTYVIO IV achieved symptom relief (remission) at Week 6, and many achieved remission at Week 52. Individual results may vary.
IV=intravenous.
Don’t wait to start a meaningful conversation with your doctor about finding the right treatment
Hear stories about how real people took action with ENTYVIO
In this video series, patients with moderate to severe ulcerative colitis or Crohn’s disease share their experiences, inspirations, and treatment journeys. We encourage you to talk to your doctor.
Mamie:
My name is Mamie. I work in television. I'm a wife of 10 years; a mother to a 9-year-old.
I like photography, I love shopping—it's one of my favorite things. Um, love to travel, go to the beach, love to swim.
I have severe Crohn's disease. I was diagnosed about 8 years ago. My daughter was less than a year old when I started having symptoms.
So, I sought out a gastroenterologist in my town. Saw him, started the battery of tests to figure out what was going on, and eventually ended up in the hospital.
I went through months of research and doctor's appointments, and they said, "No, you're just a new mom. You're just tired." But I knew that I was struggling with real symptoms.
When I was in the hospital, I had my very first colonoscopy, and that's when I was originally diagnosed.
I had a young child, I was newly married, I didn't know what this was going to mean for us. My doctor and I tried several medications, but none of them helped me with my symptoms for more than a few months. And so, I did research. And I started looking around, and I started calling people and saying, "Who do you know?"
And a friend led me in the direction of the doctor that I'm seeing now. The first time I saw him, he said, "There's so many more options for you. There are so many more choices for you, and let's get started."
He said, "You can try a drug called ENTYVIO." So, I tried ENTYVIO, and after a while, it actually began helping some of my symptoms.
And now, my doctor says I'm in remission.
I just want to let other people know that there are many options available, so you should talk to your doctor and explore those with them.
IMPORTANT SAFETY INFORMATION
- Do not receive ENTYVIO® if you have had an allergic reaction to ENTYVIO or any of its ingredients.
- ENTYVIO may cause serious side effects, including:
- Infusion-related and serious allergic reactions can happen while you are receiving ENTYVIO or several hours after treatment. You may need treatment if you have an allergic reaction. Tell your healthcare provider or get immediate medical help if you get any of these symptoms during or after an infusion of ENTYVIO: rash, itching, swelling of your lips, tongue, throat or face, shortness of breath or trouble breathing, wheezing, dizziness, feeling hot, or palpitations (feel like your heart is racing).
- Infections. ENTYVIO may increase your risk of getting a serious infection. Before and during treatment with ENTYVIO, tell your healthcare provider if you think you have an infection or symptoms of an infection, such as fever, chills, muscle aches, cough, shortness of breath, runny nose, sore throat, red or painful skin or sores on your body, tiredness, or pain during urination. If your healthcare provider feels that you are at risk for tuberculosis (TB), you may be treated with medicine for TB before you begin treatment with ENTYVIO.
- Progressive Multifocal Leukoencephalopathy (PML). People with weakened immune systems can get progressive multifocal leukoencephalopathy (PML) (a rare, serious brain infection caused by a virus). Although unlikely while receiving ENTYVIO, a risk of PML cannot be ruled out. PML can result in death or severe disability. There is no known treatment, prevention, or cure for PML. Tell your healthcare provider right away if you have any of the following symptoms: confusion or problems thinking, loss of balance, change in the way you walk or talk, decreased strength or weakness on one side of the body, blurred vision, or loss of vision.
- Liver problems can happen in people who receive ENTYVIO. Tell your healthcare provider right away if you have any of the following symptoms: tiredness, loss of appetite, pain on the right side of your abdomen, dark urine, or yellowing of the skin and eyes (jaundice).
- The most common side effects of ENTYVIO include: common cold, headache, joint pain, nausea, fever, infections of the nose and throat, tiredness, cough, bronchitis, flu, back pain, rash, itching, sinus infection, throat pain, pain in extremities, and with injections under the skin: pain, swelling, itching, hives, bruising, rash, or redness at the injection site. These are not all the possible side effects of ENTYVIO. Call your healthcare provider for medical advice about side effects.
- Before receiving ENTYVIO, tell your healthcare provider about all of your medical conditions, including if you: have or think you may have an infection or have infections that keep coming back; have liver problems; have TB or have been in close contact with someone with TB; have recently received or are scheduled to receive a vaccine; or if you are pregnant, breastfeeding, plan to become pregnant, or plan to breastfeed.
- Tell your healthcare provider about all the medicines you take, especially if you take or have recently taken Tysabri (natalizumab), Tyruko (natalizumab-sztn), a Tumor Necrosis Factor (TNF) blocker medicine, a medicine that weakens your immune system (immunosuppressant), or corticosteroid medicine.
Please see full Prescribing Information, including the Medication Guide, for ENTYVIO at ENTYVIO.com/PI and talk with your healthcare provider.
ENTYVIO is available for:
- intravenous (IV) infusion: 300 mg vedolizumab.
- subcutaneous (SC) injection: 108 mg vedolizumab.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
What is ENTYVIO (vedolizumab)?
ENTYVIO is a prescription medicine used in adults for the treatment of:
- moderately to severely active ulcerative colitis (UC).
- moderately to severely active Crohn’s disease (CD).
It is not known if ENTYVIO is safe and effective in children under 18 years of age.
Mamie, a mom with severe Crohn's disease and a job in TV, tells how a bit of networking led her to ENTYVIO.
Sheila:
My name is Sheila and I'm a CPA. I have a husband and a daughter, and we just like doing things together. We spend all our time together.
Twenty years ago, I began experiencing symptoms of Crohn's disease. Actually my husband, we were dating at the time, and he was like, "Sheila, there's something wrong with you."
I realized it was time to go to the doctor. And he referred me to a gastroenterologist, who did a colonoscopy and other testing. And so, then I was diagnosed with moderate to severe Crohn's disease.
At that time, the very common treatment was steroids. And so, I was on and off of steroids for probably a decade. Other medications, we would try 'em, and I would have limited success.
I tried to stay optimistic. I graduated college, established a career, and gave birth to my baby girl. After I had my daughter eleven years ago, I had a really bad flare-up. It was probably, it was by far the worst that I had.
And I was put on another drug, and I was on it for four years and had pretty good success. But then at about three to four years, I started developing side effects, and so I had to be taken off of that drug. So, after that, I had surgery. They cut out my ileum and one foot of my small and one foot of my large intestine. I was good, but it only lasted two years. So then, two years after surgery, I was, there I was, I was in the same position I was before. I thought I was running out of options, so my doctor recommended I try ENTYVIO.
Over time, with ENTYVIO, I started to have improvement. And I've been diagnosed to be in clinical remission.
If you have been diagnosed with Crohn's disease, one of the best things that you can do is pay attention and learn about your disease and yourself, cause everyone's different.
I've learned to take one day at a time. I visit my gastroenterologist regularly, and I take my medication.
You have to have a good relationship with your doctor. People should know that there are options, and they should talk to their doctor. I learned very early on not to hide from being sick.
To me, all you can do is find what works for you and follow your treatment, and don't be afraid to talk about it, especially with your family. You have to have a positive approach and take one day at a time.
IMPORTANT SAFETY INFORMATION
- Do not receive ENTYVIO® if you have had an allergic reaction to ENTYVIO or any of its ingredients.
- ENTYVIO may cause serious side effects, including:
- Infusion-related and serious allergic reactions can happen while you are receiving ENTYVIO or several hours after treatment. You may need treatment if you have an allergic reaction. Tell your healthcare provider or get immediate medical help if you get any of these symptoms during or after an infusion of ENTYVIO: rash, itching, swelling of your lips, tongue, throat or face, shortness of breath or trouble breathing, wheezing, dizziness, feeling hot, or palpitations (feel like your heart is racing).
- Infections. ENTYVIO may increase your risk of getting a serious infection. Before and during treatment with ENTYVIO, tell your healthcare provider if you think you have an infection or symptoms of an infection, such as fever, chills, muscle aches, cough, shortness of breath, runny nose, sore throat, red or painful skin or sores on your body, tiredness, or pain during urination. If your healthcare provider feels that you are at risk for tuberculosis (TB), you may be treated with medicine for TB before you begin treatment with ENTYVIO.
- Progressive Multifocal Leukoencephalopathy (PML). People with weakened immune systems can get progressive multifocal leukoencephalopathy (PML) (a rare, serious brain infection caused by a virus). Although unlikely while receiving ENTYVIO, a risk of PML cannot be ruled out. PML can result in death or severe disability. There is no known treatment, prevention, or cure for PML. Tell your healthcare provider right away if you have any of the following symptoms: confusion or problems thinking, loss of balance, change in the way you walk or talk, decreased strength or weakness on one side of the body, blurred vision, or loss of vision.
- Liver problems can happen in people who receive ENTYVIO. Tell your healthcare provider right away if you have any of the following symptoms: tiredness, loss of appetite, pain on the right side of your abdomen, dark urine, or yellowing of the skin and eyes (jaundice).
- The most common side effects of ENTYVIO include: common cold, headache, joint pain, nausea, fever, infections of the nose and throat, tiredness, cough, bronchitis, flu, back pain, rash, itching, sinus infection, throat pain, pain in extremities, and with injections under the skin: pain, swelling, itching, hives, bruising, rash, or redness at the injection site. These are not all the possible side effects of ENTYVIO. Call your healthcare provider for medical advice about side effects.
- Before receiving ENTYVIO, tell your healthcare provider about all of your medical conditions, including if you: have or think you may have an infection or have infections that keep coming back; have liver problems; have TB or have been in close contact with someone with TB; have recently received or are scheduled to receive a vaccine; or if you are pregnant, breastfeeding, plan to become pregnant, or plan to breastfeed.
- Tell your healthcare provider about all the medicines you take, especially if you take or have recently taken Tysabri (natalizumab), Tyruko (natalizumab-sztn), a Tumor Necrosis Factor (TNF) blocker medicine, a medicine that weakens your immune system (immunosuppressant), or corticosteroid medicine.
Please see full Prescribing Information, including the Medication Guide, for ENTYVIO at ENTYVIO.com/PI and talk with your healthcare provider.
ENTYVIO is available for:
- intravenous (IV) infusion: 300 mg vedolizumab.
- subcutaneous (SC) injection: 108 mg vedolizumab.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
What is ENTYVIO (vedolizumab)?
ENTYVIO is a prescription medicine used in adults for the treatment of:
- moderately to severely active ulcerative colitis (UC).
- moderately to severely active Crohn’s disease (CD).
It is not known if ENTYVIO is safe and effective in children under 18 years of age.
Sheila provides a vivid snapshot of living with moderate to severe Crohn's disease and her treatment journey that led to ENTYVIO.
Sheila:
So, at 20 years old, I was diagnosed with Crohn's after a colonoscopy.
I was on lots of different medications for about eight years up and down, just going from one flare to the next. So went and talked to my doctor, and he recommended ENTYVIO.
Kate:
The decision to start ENTYVIO was, uh, was a joint one, um, even though it was sort of driven by me because I had heard about it. Uh, we both thought ENTYVIO would be great for me and it, it turned out to be a really good fit.
Dan:
I had tried several other drugs, and not much relief. After seven years of trying the same old same old and feeling the same way, I decided that it was time for a change. So, I'd made the decision at that point that I'm gonna try ENTYVIO.
Jen:
When I learned the science behind ENTYVIO, was, that's when I said okay. That was when I made the decision, all right, let's do this.
IMPORTANT SAFETY INFORMATION
- Do not receive ENTYVIO® if you have had an allergic reaction to ENTYVIO or any of its ingredients.
- ENTYVIO may cause serious side effects, including:
- Infusion-related and serious allergic reactions can happen while you are receiving ENTYVIO or several hours after treatment. You may need treatment if you have an allergic reaction. Tell your healthcare provider or get immediate medical help if you get any of these symptoms during or after an infusion of ENTYVIO: rash, itching, swelling of your lips, tongue, throat or face, shortness of breath or trouble breathing, wheezing, dizziness, feeling hot, or palpitations (feel like your heart is racing).
- Infections. ENTYVIO may increase your risk of getting a serious infection. Before and during treatment with ENTYVIO, tell your healthcare provider if you think you have an infection or symptoms of an infection, such as fever, chills, muscle aches, cough, shortness of breath, runny nose, sore throat, red or painful skin or sores on your body, tiredness, or pain during urination. If your healthcare provider feels that you are at risk for tuberculosis (TB), you may be treated with medicine for TB before you begin treatment with ENTYVIO.
- Progressive Multifocal Leukoencephalopathy (PML). People with weakened immune systems can get progressive multifocal leukoencephalopathy (PML) (a rare, serious brain infection caused by a virus). Although unlikely while receiving ENTYVIO, a risk of PML cannot be ruled out. PML can result in death or severe disability. There is no known treatment, prevention, or cure for PML. Tell your healthcare provider right away if you have any of the following symptoms: confusion or problems thinking, loss of balance, change in the way you walk or talk, decreased strength or weakness on one side of the body, blurred vision, or loss of vision.
- Liver problems can happen in people who receive ENTYVIO. Tell your healthcare provider right away if you have any of the following symptoms: tiredness, loss of appetite, pain on the right side of your abdomen, dark urine, or yellowing of the skin and eyes (jaundice).
- The most common side effects of ENTYVIO include: common cold, headache, joint pain, nausea, fever, infections of the nose and throat, tiredness, cough, bronchitis, flu, back pain, rash, itching, sinus infection, throat pain, pain in extremities, and with injections under the skin: pain, swelling, itching, hives, bruising, rash, or redness at the injection site. These are not all the possible side effects of ENTYVIO. Call your healthcare provider for medical advice about side effects.
- Before receiving ENTYVIO, tell your healthcare provider about all of your medical conditions, including if you: have or think you may have an infection or have infections that keep coming back; have liver problems; have TB or have been in close contact with someone with TB; have recently received or are scheduled to receive a vaccine; or if you are pregnant, breastfeeding, plan to become pregnant, or plan to breastfeed.
- Tell your healthcare provider about all the medicines you take, especially if you take or have recently taken Tysabri (natalizumab), Tyruko (natalizumab-sztn), a Tumor Necrosis Factor (TNF) blocker medicine, a medicine that weakens your immune system (immunosuppressant), or corticosteroid medicine.
Please see full Prescribing Information, including the Medication Guide, for ENTYVIO at ENTYVIO.com/PI and talk with your healthcare provider.
ENTYVIO is available for:
- intravenous (IV) infusion: 300 mg vedolizumab.
- subcutaneous (SC) injection: 108 mg vedolizumab.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
What is ENTYVIO (vedolizumab)?
ENTYVIO is a prescription medicine used in adults for the treatment of:
- moderately to severely active ulcerative colitis (UC).
- moderately to severely active Crohn’s disease (CD).
It is not known if ENTYVIO is safe and effective in children under 18 years of age.
Patients talk about the individual journeys that led them to ENTYVIO. Your experience may vary.
Ron:
So, this is the... this is the first medication that I ever went on that was an infusion. Um, others were injections or oral. I had no expectation of... of... you know, returning to what we'll call before the disease, um, but was hopeful that it would at least reduce the symptoms.
Dan:
After being on ENTYVIO for two to three months, I knew something was changing. It wasn't anything I could notice on a daily basis... but when I had looked back to when I started the medication...
I looked... said, "Hey I just drove by the restroom on a three-hour road trip here and I didn't even think about stopping. That hasn't happened before." It was kind of at that time I could tell things were different.
Kate:
Mine was really, um, a gradual climb. It was not immediate, it was not overnight, but it definitely after a couple of months, I was noticing that I was feeling much better and my symptoms were much, uh, much lighter than they had been before. I noticed I was, uh, using the bathroom less and less, um, and yeah, it was, it was nice.
Sheila:
I mean, you have to laugh at yourself... your parents tell you that when you're little, if you slip and fall just laugh it off, get up. And I think it's the same thing for me with this disease and getting through it... even in remission, things don't always act normal, you still have an underlying chronic condition. Don't let it define you, don't let it stop you, don't let it upset you, it is what it is and let's just move to the next step.
Ron:
And to not be chained to a bathroom anymore is just you know really been liberating... Um... just really amazing.
IMPORTANT SAFETY INFORMATION
- Do not receive ENTYVIO® if you have had an allergic reaction to ENTYVIO or any of its ingredients.
- ENTYVIO may cause serious side effects, including:
- Infusion-related and serious allergic reactions can happen while you are receiving ENTYVIO or several hours after treatment. You may need treatment if you have an allergic reaction. Tell your healthcare provider or get immediate medical help if you get any of these symptoms during or after an infusion of ENTYVIO: rash, itching, swelling of your lips, tongue, throat or face, shortness of breath or trouble breathing, wheezing, dizziness, feeling hot, or palpitations (feel like your heart is racing).
- Infections. ENTYVIO may increase your risk of getting a serious infection. Before and during treatment with ENTYVIO, tell your healthcare provider if you think you have an infection or symptoms of an infection, such as fever, chills, muscle aches, cough, shortness of breath, runny nose, sore throat, red or painful skin or sores on your body, tiredness, or pain during urination. If your healthcare provider feels that you are at risk for tuberculosis (TB), you may be treated with medicine for TB before you begin treatment with ENTYVIO.
- Progressive Multifocal Leukoencephalopathy (PML). People with weakened immune systems can get progressive multifocal leukoencephalopathy (PML) (a rare, serious brain infection caused by a virus). Although unlikely while receiving ENTYVIO, a risk of PML cannot be ruled out. PML can result in death or severe disability. There is no known treatment, prevention, or cure for PML. Tell your healthcare provider right away if you have any of the following symptoms: confusion or problems thinking, loss of balance, change in the way you walk or talk, decreased strength or weakness on one side of the body, blurred vision, or loss of vision.
- Liver problems can happen in people who receive ENTYVIO. Tell your healthcare provider right away if you have any of the following symptoms: tiredness, loss of appetite, pain on the right side of your abdomen, dark urine, or yellowing of the skin and eyes (jaundice).
- The most common side effects of ENTYVIO include: common cold, headache, joint pain, nausea, fever, infections of the nose and throat, tiredness, cough, bronchitis, flu, back pain, rash, itching, sinus infection, throat pain, pain in extremities, and with injections under the skin: pain, swelling, itching, hives, bruising, rash, or redness at the injection site. These are not all the possible side effects of ENTYVIO. Call your healthcare provider for medical advice about side effects.
- Before receiving ENTYVIO, tell your healthcare provider about all of your medical conditions, including if you: have or think you may have an infection or have infections that keep coming back; have liver problems; have TB or have been in close contact with someone with TB; have recently received or are scheduled to receive a vaccine; or if you are pregnant, breastfeeding, plan to become pregnant, or plan to breastfeed.
- Tell your healthcare provider about all the medicines you take, especially if you take or have recently taken Tysabri (natalizumab), Tyruko (natalizumab-sztn), a Tumor Necrosis Factor (TNF) blocker medicine, a medicine that weakens your immune system (immunosuppressant), or corticosteroid medicine.
Please see accompanying full Prescribing Information, including the Medication Guide, for ENTYVIO and talk with your healthcare provider.
ENTYVIO is available for:
- intravenous (IV) infusion: 300 mg vedolizumab.
- subcutaneous (SC) injection: 108 mg vedolizumab.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
What is ENTYVIO (vedolizumab)?
ENTYVIO is a prescription medicine used in adults for the treatment of:
- moderately to severely active ulcerative colitis (UC).
- moderately to severely active Crohn’s disease (CD).
It is not known if ENTYVIO is safe and effective in children under 18 years of age.
Patients taking ENTYVIO describe the treatment and how it has helped them manage their condition. Your experience may vary.
What is ENTYVIO (vedolizumab)?
ENTYVIO is a prescription medicine used in adults for the treatment of:
- moderately to severely active ulcerative colitis (UC).
- moderately to severely active Crohn's disease (CD).
It is not known if ENTYVIO is safe and effective in children under 18 years of age.
SELECTED SAFETY INFORMATION
Do not receive ENTYVIO if you have had an allergic reaction to ENTYVIO or any of its ingredients. ENTYVIO may cause serious side effects, including infusion-related and serious allergic reactions, while receiving ENTYVIO or several hours after treatment. ENTYVIO may increase your risk of serious infections. If your healthcare provider feels that you are at risk for tuberculosis (TB), you may be treated with medicine for TB before you begin treatment with ENTYVIO. Although unlikely, progressive multifocal leukoencephalopathy (PML), a rare, serious brain infection caused by a virus, cannot be ruled out. Liver problems can occur with ENTYVIO.
Please see full Important Safety Information at the end of this video.
Daniel:
The first thing I do on infusion day is make a cup of coffee and then I start to get ready for my ENTYVIO treatment.
Jen:
It takes me about 30 minutes to drive to my infusion center. I use the time to transition from my busy life and relax mentally.
Daniel:
I get my ENTYVIO at-home infusion kit and my collapsible IV pole out from underneath my bed where I store them.
Jen:
When I walk through the infusion center door, I'm always greeted by smiling faces. The staff treats me like family.
Dan:
I take my ENTYVIO dose out of the refrigerator and I lay everything on the table so that it's ready to go.
Jen:
I'm escorted down the hall to my own private room and the nurse ensures I have everything I need to feel comfortable.
Both:
I sit down in my chair and I'm ready to receive my infusion.
Dan:
I'm Daniel, I've been living with moderate to severe ulcerative colitis since 2006. I like to stay as active as I possibly can, and I always knew that I would need a treatment plan and a management plan that would work well with my active lifestyle.
Jen:
I'm Jen, and I was diagnosed with Crohn's disease in 2001 and ulcerative colitis in 2017. I'm a mother of two children, and they're my world. I knew I needed to be my own best advocate and find options that would work with my schedule.
Cassidy:
I'm Cassidy, and I'm a nurse working with patients receiving infusion therapies. Infusions can be unfamiliar and seem scary at first. It is important that patients know their options and what the infusion process can look like. Some of these infusions can be administered here at an infusion center. Or here in the patient's home. It is my job as an infusion nurse to ensure the patients receive the same quality of care, regardless of their infusion setting.
Jen:
My doctor prescribed me ENTYVIO to treat my moderately to severely active Crohn's disease when other options weren't working. We talked about the potential serious side effects as well as common side effects including common cold, headache, joint pain, and nausea. These are not all of the side effects of ENTYVIO. My doctor also talked to me about the importance of monitoring for any side effects and working with my healthcare team to manage them. After prescribing ENTYVIO, my doctor and I felt it would be right for me to receive my infusions at a center. We looked into different infusion centers in my area and found one that was right for me. My doctor's office set up my first appointment, and together, we completed my initial paperwork.
Dan:
For about two years, I'd been receiving my ENTYVIO infusions at the hospital to treat my moderate to severe ulcerative colitis.
This followed an induction period to help me start ENTYVIO. When starting ENTYVIO, my healthcare provider told me about the potential serious side effects, including infusion-related and serious allergic reactions. Increased risk of getting a serious infection, PML in people with weakened immune systems, and liver problems.
When my insurance provider switched my treatment so that I would receive at-home infusions, I was hesitant at first.
My provider helped me to arrange getting my medication delivered to me in the mail.
Soon I realized how easy the process could be and how easy it was for me to not have to leave my home to get my infusion.
Cassidy:
The team of nurses at an infusion center work together to provide continuous care to our patients.
My patients like having access to all the in-person resources available in the infusion center, such as pharmacists, treatment consultants, and planners.
Jen:
Although I was nervous at first about possible complications with my infusion process, the atmosphere at the infusion center quickly put my mind at ease.
It's nice to know that I'm in a fully-equipped medical center with a skilled clinical team should any challenges occur during my ENTYVIO infusions.
I know that there are strict protocols in place to provide a sterile and safe environment.
Cassidy:
At-home infusions provide patients a way to receive their treatment who otherwise would not have had access to an infusion center.
A visiting nurse in an at-home setting works to provide patients with the same resources over the phone that they otherwise would have access to in the infusion center, for example, answering patients’ questions about their treatment.
Dan:
Any concerns I had about arranging the logistics of getting my ENTYVIO infusion at home are long gone.
I've had the same nurse since I started my at-home ENTYVIO infusions.
When she arrives, she disinfects her work area and prepares my medication.
During the 30 minutes that it takes for me to actually get the infusion, my nurse will monitor me during that time and we'll also talk about each other's lives.
After my infusion is done, my nurse will monitor me just to make sure there's no complications.
Jen:
I like that every aspect of my infusion is taken care of by my nurse at the infusion center.
During my infusion, I just sit back and mentally unwind. I'm grateful for the little breaks that my visits to the infusion center give me to decompress from my hectic life as a mother.
My nurse monitors me after my infusion. Then afterwards, I just get up and go. I'm lucky that my infusion center handles all of my insurance paperwork. I don't have to worry about a thing.
Dan:
I found that the EntyvioConnect program can be a great support system. It's available even when my infusion nurse can't be. They can help guide me through my treatment journey, navigate insurance coverage questions and remind me of upcoming treatments. They help ease the stress of managing my at-home infusions.
This is just my experience, but each patient's experience may be different.
Both:
My ENTYVIO infusion setting is right for me.
IMPORTANT SAFETY INFORMATION
- Do not receive ENTYVIO® if you have had an allergic reaction to ENTYVIO or any of its ingredients.
- ENTYVIO may cause serious side effects, including:
- Infusion-related and serious allergic reactions can happen while you are receiving ENTYVIO or several hours after treatment. You may need treatment if you have an allergic reaction. Tell your healthcare provider or get immediate medical help if you get any of these symptoms during or after an infusion of ENTYVIO: rash, itching, swelling of your lips, tongue, throat or face, shortness of breath or trouble breathing, wheezing, dizziness, feeling hot, or palpitations (feel like your heart is racing).
- Infections. ENTYVIO may increase your risk of getting a serious infection. Before and during treatment with ENTYVIO, tell your healthcare provider if you think you have an infection or symptoms of an infection, such as fever, chills, muscle aches, cough, shortness of breath, runny nose, sore throat, red or painful skin or sores on your body, tiredness, or pain during urination. If your healthcare provider feels that you are at risk for tuberculosis (TB), you may be treated with medicine for TB before you begin treatment with ENTYVIO.
- Progressive Multifocal Leukoencephalopathy (PML). People with weakened immune systems can get progressive multifocal leukoencephalopathy (PML) (a rare, serious brain infection caused by a virus). Although unlikely while receiving ENTYVIO, a risk of PML cannot be ruled out. PML can result in death or severe disability. There is no known treatment, prevention, or cure for PML. Tell your healthcare provider right away if you have any of the following symptoms: confusion or problems thinking, loss of balance, change in the way you walk or talk, decreased strength or weakness on one side of the body, blurred vision, or loss of vision.
- Liver problems can happen in people who receive ENTYVIO. Tell your healthcare provider right away if you have any of the following symptoms: tiredness, loss of appetite, pain on the right side of your abdomen, dark urine, or yellowing of the skin and eyes (jaundice).
- The most common side effects of ENTYVIO include: common cold, headache, joint pain, nausea, fever, infections of the nose and throat, tiredness, cough, bronchitis, flu, back pain, rash, itching, sinus infection, throat pain, pain in extremities, and with injections under the skin: pain, swelling, itching, hives, bruising, rash, or redness at the injection site. These are not all the possible side effects of ENTYVIO. Call your healthcare provider for medical advice about side effects.
- Before receiving ENTYVIO, tell your healthcare provider about all of your medical conditions, including if you: have or think you may have an infection or have infections that keep coming back; have liver problems; have TB or have been in close contact with someone with TB; have recently received or are scheduled to receive a vaccine; or if you are pregnant, breastfeeding, plan to become pregnant, or plan to breastfeed.
- Tell your healthcare provider about all the medicines you take, especially if you take or have recently taken Tysabri (natalizumab), Tyruko (natalizumab-sztn), a Tumor Necrosis Factor (TNF) blocker medicine, a medicine that weakens your immune system (immunosuppressant), or corticosteroid medicine.
Please see accompanying full Prescribing Information, including the Medication Guide, for ENTYVIO and talk with your healthcare provider.
ENTYVIO is available for:
- intravenous (IV) infusion: 300 mg vedolizumab.
- subcutaneous (SC) injection: 108 mg vedolizumab.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
What is ENTYVIO (vedolizumab)?
ENTYVIO is a prescription medicine used in adults for the treatment of:
- moderately to severely active ulcerative colitis (UC).
- moderately to severely active Crohn’s disease (CD).
It is not known if ENTYVIO is safe and effective in children under 18 years of age.
Learn about the various approved infusion options for treatment with ENTYVIO.
Sheila:
Some people are afraid of needles or injections.
I wouldn't be nervous about the infusion, um, it's, it's not hard.
Dan:
Yeah, it's not that scary. Uh, you go, and you get the line in, and um after the IV line's in and the, the bag's hooked up, it just takes about 30 minutes and the infusion center I went to, they had a little TV, so I was able to watch the news when I was getting my infusion done.
Kate:
Sometimes you end up meeting people who happen to be there at the same time, and it's nice to see those familiar faces again. I made a friend who had Crohn's disease, and we would actually be infusion buddies. So we would schedule our infusions at the same time and then go have lunch together.
Ron:
So you, you do have to go in for infusions every eight weeks, and that, that little bit of fear and anticipation of having to go in and have a needle stuck in you... The advice is... it's all worth it, If this medication works for you, it's worth it.
IMPORTANT SAFETY INFORMATION
- Do not receive ENTYVIO® if you have had an allergic reaction to ENTYVIO or any of its ingredients.
- ENTYVIO may cause serious side effects, including:
- Infusion-related and serious allergic reactions can happen while you are receiving ENTYVIO or several hours after treatment. You may need treatment if you have an allergic reaction. Tell your healthcare provider or get immediate medical help if you get any of these symptoms during or after an infusion of ENTYVIO: rash, itching, swelling of your lips, tongue, throat or face, shortness of breath or trouble breathing, wheezing, dizziness, feeling hot, or palpitations (feel like your heart is racing).
- Infections. ENTYVIO may increase your risk of getting a serious infection. Before and during treatment with ENTYVIO, tell your healthcare provider if you think you have an infection or symptoms of an infection, such as fever, chills, muscle aches, cough, shortness of breath, runny nose, sore throat, red or painful skin or sores on your body, tiredness, or pain during urination. If your healthcare provider feels that you are at risk for tuberculosis (TB), you may be treated with medicine for TB before you begin treatment with ENTYVIO.
- Progressive Multifocal Leukoencephalopathy (PML). People with weakened immune systems can get progressive multifocal leukoencephalopathy (PML) (a rare, serious brain infection caused by a virus). Although unlikely while receiving ENTYVIO, a risk of PML cannot be ruled out. PML can result in death or severe disability. There is no known treatment, prevention, or cure for PML. Tell your healthcare provider right away if you have any of the following symptoms: confusion or problems thinking, loss of balance, change in the way you walk or talk, decreased strength or weakness on one side of the body, blurred vision, or loss of vision.
- Liver problems can happen in people who receive ENTYVIO. Tell your healthcare provider right away if you have any of the following symptoms: tiredness, loss of appetite, pain on the right side of your abdomen, dark urine, or yellowing of the skin and eyes (jaundice).
- The most common side effects of ENTYVIO include: common cold, headache, joint pain, nausea, fever, infections of the nose and throat, tiredness, cough, bronchitis, flu, back pain, rash, itching, sinus infection, throat pain, pain in extremities, and with injections under the skin: pain, swelling, itching, hives, bruising, rash, or redness at the injection site. These are not all the possible side effects of ENTYVIO. Call your healthcare provider for medical advice about side effects.
- Before receiving ENTYVIO, tell your healthcare provider about all of your medical conditions, including if you: have or think you may have an infection or have infections that keep coming back; have liver problems; have TB or have been in close contact with someone with TB; have recently received or are scheduled to receive a vaccine; or if you are pregnant, breastfeeding, plan to become pregnant, or plan to breastfeed.
- Tell your healthcare provider about all the medicines you take, especially if you take or have recently taken Tysabri (natalizumab), Tyruko (natalizumab-sztn), a Tumor Necrosis Factor (TNF) blocker medicine, a medicine that weakens your immune system (immunosuppressant), or corticosteroid medicine.
Please see accompanying full Prescribing Information, including the Medication Guide, for ENTYVIO and talk with your healthcare provider.
ENTYVIO is available for:
- intravenous (IV) infusion: 300 mg vedolizumab.
- subcutaneous (SC) injection: 108 mg vedolizumab.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
What is ENTYVIO (vedolizumab)?
ENTYVIO is a prescription medicine used in adults for the treatment of:
- moderately to severely active ulcerative colitis (UC).
- moderately to severely active Crohn’s disease (CD).
It is not known if ENTYVIO is safe and effective in children under 18 years of age.
Learn what it’s like to get an infusion and get tips for what to bring to your infusion appointment. Your experience may vary.
Talk to people who understand through the patient mentor program
Our ambassadors know firsthand what living with Crohn's is like and are here to help you learn more.
